Neuromodulatory Technologies Offer New Hope for Psychiatric Disorders
Recent advancements in neuromodulatory technologies are providing new treatment options for psychiatric and neuropsychiatric conditions. These technologies, which include transcranial magnetic stimulation (TMS), transcranial direct-current stimulation (tDCS), and noninvasive vagus nerve stimulation (nVNS), aim to alter neural activity by delivering electrical stimulation to the nervous system. They are increasingly recognized for their potential to treat conditions such as major depressive disorder (MDD), posttraumatic stress disorder (PTSD), and chronic pain. The technologies move beyond symptom suppression, targeting neural circuits involved in mood, cognition, and pain. Wearable devices that monitor physiological responses are also being integrated with these technologies to provide personalized treatment options. 
